Pregnant women diagnosed during the first wave of COVID-19 had higher frequency of maternal morbidities<\/p>\n<\/h3>\n
<\/b><\/p>\n
<\/b><\/p>\n
THURSDAY, Dec. 2, 2021 (HealthDay News) — Maternal morbidities are more common among pregnant women diagnosed with COVID-19 versus pregnant women without COVID-19, according to a study published online Nov. 30 in PLOS Medicine<\/em>.<\/p>\n Sylvie Epelboin, M.D., from the Universit \u00a9 de Paris, and colleagues assessed whether maternal morbidities were more frequent in pregnant women with a COVID-19 diagnosis compared to pregnant women without a COVID-19 diagnosis during the first wave of the COVID-19 pandemic (January to June 2020). The analysis included 244,645 births, including 0.36 percent in the COVID-19 group.<\/p>\n The researchers found that among pregnant women, older age, obesity, multiple pregnancy, and history of hypertension were more frequent with a COVID-19 diagnosis, while active smoking and primiparity were less frequent with a COVID-19 diagnosis. Women with COVID-19 had a higher frequency of admission to the intensive care unit; mortality; preeclampsia\/eclampsia; gestational hypertension; postpartum hemorrhage; preterm birth at <37 weeks of gestation, <32 weeks of gestation, and <28 weeks of gestation; induced preterm birth; spontaneous preterm birth; fetal distress; and cesarean section versus women without COVID-19. There were no significant differences noted between the groups for rates of pregnancy terminations \u00e2\u0089\u00a522 weeks of gestation, stillbirths, gestational diabetes, placenta previa, or placenta abruption.<\/p>\n “Although causality cannot be determined from these associations, these results may be in line with recent recommendations in favor of vaccination for pregnant women,” the authors write.<\/p>\n One author disclosed financial ties to the pharmaceutical industry.<\/p>\n